Mar 1, 2017
This week, we kick off with a mixed bag of topics including some notable announcements from Rogers and our thoughts on OPEC’s agreed production cut. In our Your Stock Our Take Segment we review a viewer question on profitable and growing TSX-Venture listed specialty pharma stock BioSyent Inc. (RX:TSX-V). And in our Stars and Dogs of the week we review this year’s largest Canadian IPO, retailer Aritzia Inc. (ATX:TSX) and industrial chemical manufacturer Canexus Corporation (CUS:TSX).